Relevant bibliographies by topics / Syndrome. Polycystic Ovary. Treatment

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Syndrome. Polycystic Ovary. Treatment'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Syndrome. Polycystic Ovary. Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Whitaker, Kristin Nadine. "Polycystic Ovary Syndrome." Journal of Pharmacy Practice 24, no. 1 (2010): 94–101. http://dx.doi.org/10.1177/0897190010384632.

Full text
Abstract:
Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. It affects 6% to 7% of the population and is characterized by hyperandrogenism and ovarian dysfunction. Women with the disorder often present with insulin resistance and obesity, making it importance for health care providers to monitor closely for signs and symptoms of metabolic syndrome and type 2 diabetes. Treatments are targeted toward improving insulin tolerance, reducing signs and symptoms of hyperandrogenism (hirsutism, anovulation, etc), restoring normal menstrual cycle function, and restoring
APA, Harvard, Vancouver, ISO, and other styles
2

Somagutta, Manoj Reddy, Molly Jain, Utkarsha Uday, et al. "Novel Antidiabetic Medications in Polycystic Ovary Syndrome." Discoveries 10, no. 1 (2022): e145. http://dx.doi.org/10.15190/d.2022.4.

Full text
Abstract:
Polycystic ovary syndrome is a very common endocrine disorder prevalent in premenopausal women. Patients with polycystic ovary syndrome present with abnormal menstruation, ovulation disorders, and hyperandrogenemia. They are often accompanied by insulin resistance, metabolic disorders, and other cardiovascular abnormalities. Also, they have comorbidities, such as dyslipidemia, obesity, diabetes type 2, non-alcoholic fatty liver disease, which all influence the treatment plan. Metformin has been defined as a treatment option in patients with polycystic ovary syndrome. However, the clinical resp
APA, Harvard, Vancouver, ISO, and other styles
3

Carol Gabriela Guerrero Acevedo and Jairo Alejandro Estrada Morales. "Polycystic ovary syndrome." GSC Biological and Pharmaceutical Sciences 31, no. 1 (2025): 163–72. https://doi.org/10.30574/gscbps.2025.31.1.0129.

Full text
Abstract:
Polycystic Ovary Syndrome (PCOS) is a heterogeneous disorder and a frequent cause of consultation in adolescents. The etiology is multifactorial, involving genetic and environmental factors (intrauterine and extrauterine).1 The clinical manifestations are hirsutism, menstrual irregularities, and acne. In addition, metabolic alterations such as hyperinsulinemia, insulin resistance, dyslipidemia and obesity are also associated.2 The objectives of the treatment are to achieve ovulation, normalize menstrual cycles, reduce and if possible, eliminate hirsutism and acne, obtain an acceptable weight l
APA, Harvard, Vancouver, ISO, and other styles
4

Mayhew, Maren S. "Treatment for Polycystic Ovary Syndrome." Journal for Nurse Practitioners 7, no. 6 (2011): 517–18. http://dx.doi.org/10.1016/j.nurpra.2011.04.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Szymura, Marta, Marek Jarosław Molenda, Oliwia Brygida Woszczyńska, et al. "Polycystic Ovary Syndrome - treatment update." Quality in Sport 43 (July 12, 2025): 61348. https://doi.org/10.12775/qs.2025.43.61348.

Full text
Abstract:
Introduction: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders. It gets its name from the characteristic appearance of the ovaries observed in ultrasound imaging. Statistically, PCOS affects about 4-12% of women of reproductive age. PCOS can have a variety of symptoms and courses, and its causes have not been fully understood. Women with PCOS are at a higher risk of developing diabetes, hypertension, hyperlipidemia, and endometrial cancer compared to their healthy peers. The purpose of our work is to discuss the available methods used in the treatment of this synd
APA, Harvard, Vancouver, ISO, and other styles
6

Louwers, Yvonne V., and Joop S. E. Laven. "Characteristics of polycystic ovary syndrome throughout life." Therapeutic Advances in Reproductive Health 14 (January 2020): 263349412091103. http://dx.doi.org/10.1177/2633494120911038.

Full text
Abstract:
Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. It is a complex disease in which genetic, endocrine, environmental, and behavioral factors are intertwined, giving rise to a heterogeneous phenotype with reproductive, metabolic, and psychological characteristics. Polycystic ovary syndrome affects women’s health and their quality of life across the life course. During different life stages, the polycystic ovary syndrome phenotype can change, which requires a personalized diagnostic approach and treatment. Polycystic ovary syndrome is a major cause of
APA, Harvard, Vancouver, ISO, and other styles
7

Azizova, M. E. "Polycystic ovary syndrome - modern concepts." Kazan medical journal 96, no. 1 (2015): 77–80. http://dx.doi.org/10.17750/kmj2015-077.

Full text
Abstract:
The article reviews current concepts of etiology and pathogenesis of polycystic ovary syndrome. Currently, numerous forms of the syndrome, manifesting by a variety of clinical, morphologic signs and features of endocrine profile, exist. It was revealed that polycystic ovary syndrome is a multifactorial, genetically determined disease. Laboratory diagnosis in females with polycystic ovary syndrome is based on measuring concentrations of hormones. Results of ovarian sonography are of a great importance, allowing to diagnose polycystic ovary syndrome. Another method of instrumental diagnosis is l
APA, Harvard, Vancouver, ISO, and other styles
8

Bogatyreva, E. M., and G. A. Novik. "Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance." Bulletin of Siberian Medicine 17, no. 2 (2018): 13–20. http://dx.doi.org/10.20538/1682-0363-2018-2-13-20.

Full text
Abstract:
Aim. Polycystic ovary syndrome is a common cause of infertility. In addition, polycystic ovary syndrome is often associated with metabolic complications. In most women hyperandrogenic manifestations occur during puberty. Early detection of polycystic ovary syndrome and associated metabolic problems can solve the problem of puberty and prevent infertility, metabolic syndrome, and diabetes mellitus type 2 in women of reproductive age. One of the objectives of the study was to evaluate the effectiveness of the simultaneous use of a combined oral preparation (ethinyl estradiol + drospirenone) and
APA, Harvard, Vancouver, ISO, and other styles
9

Spinedi, Eduardo, and Daniel P. Cardinali. "The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy." International Journal of Endocrinology 2018 (July 25, 2018): 1–12. http://dx.doi.org/10.1155/2018/1349868.

Full text
Abstract:
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without compensatory hyperinsulinemia, and hyperandrogenism are very common features of the polycystic ovary syndrome phenotype. Dysfunctional white adipose tissue has been identified as a major contributing factor for insulin resistance in polycystic ovary syndrome. Environmental (e.g., chronodisruption) and genetic/epigenetic factors may also play relevant
APA, Harvard, Vancouver, ISO, and other styles
10

Romualdi, Daniela, Valeria Versace, and Antonio Lanzone. "What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment." Therapeutic Advances in Reproductive Health 14 (January 2020): 263349412090870. http://dx.doi.org/10.1177/2633494120908709.

Full text
Abstract:
Polycystic ovary syndrome, the most common gynecological endocrinopathy, is burdened with a state of hyperinsulinemia and insulin resistance in 50–80% of affected women. Wherever the origin of these metabolic abnormalities lies, their pathogenetic role in determining, perpetuating, and worsening the clinical traits of the syndrome is ascertained. Many studies have already highlighted possible mechanisms: hyperinsulinemia and insulin resistance may contribute to hyperandrogenemia, chronic anovulation, and other comorbidities of the syndrome by differentially affecting the endocrine glands (ovar
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Patterson, Moneka Angilene. "Polycystic Ovary Syndrome Treatment." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4319.

Full text
Abstract:
Polycystic ovary syndrome (PCOS) is an endocrine system disorder that affects women of reproductive age. If not treated properly, PCOS can lead to infertility. Lack of proper treatment of PCOS may also result in medical complications such as diabetes or heart disease. The rural clinic where this project took place did not have a mandatory guideline for treatment of PCOS; therefore, no standardized method of diagnosis or treatment of PCOS existed. The purpose of this project, guided by the IOWA evidence-based practice model, was to educate providers on the evidence-based guideline for diagnosis
APA, Harvard, Vancouver, ISO, and other styles
2

Vanky, Eszter. "Polycystic ovary syndrome - Metformin treatment in pregnancy." Doctoral thesis, Norwegian University of Science and Technology, Faculty of Medicine, 2005. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-688.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pellatt, Laura Jane. "Metformin treatment in polycystic ovary syndrome : single drug, triple benefit?" Thesis, St George's, University of London, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.511953.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bützow, Tarja. "Gonadotropins and metabolic features in the pathophysiology and treatment of polycystic ovary syndrome." Helsinki : University of Helsinki, 2000. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/butzow/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Naessén, Sabine. "Endocrine and metabolic disorders in bulimic women and effects of antiandrogenic treatment /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7357-003-6/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Morin-Papunen, L. (Laure). "Insulin resistance in polycystic ovary syndrome." Doctoral thesis, University of Oulu, 2000. http://urn.fi/urn:isbn:9514257405.

Full text
Abstract:
Abstract The polycystic ovary syndrome, described first as the association of bilateral polycystic ovaries and amenorrhoea, oligomenorrhoea, hirsutism and obesity, was later shown to be a complex metabolic syndrome. The first purpose of this study was to investigate the occurrence of hyperinsulinaemia and the severity of insulin resistance and glucose tolerance disorders in polycystic ovary syndrome by means of the oral glucose tolerance test and the euglycaemic hyperinsulinaemic clamp. The next goal was to investigate whether women with polycystic ovary syndrome would benefit from insulin-se
APA, Harvard, Vancouver, ISO, and other styles
7

Cho, Li Wei. "Cardiometabolic aspects of polycystic ovary syndrome." Thesis, University of Hull, 2008. http://hydra.hull.ac.uk/resources/hull:5826.

Full text
Abstract:
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 6-7% of the population. It is characterised by chronic anovulation and hyperandrogenism with the clinical manifestation of oligomenorrhoea, hirsutism and acne. A ten to twenty fold increased risk for type 2 diabetes in PCOS patients compared to weight matched female control subjects makes the syndrome of high socioeconomic importance. The use of differing diagnostic criteria makes the comparison of studies on PCOS difficult until harmonisation through the Rotterdam consensus in 2004. Despite being removed from the diagno
APA, Harvard, Vancouver, ISO, and other styles
8

Yasmin, Ephia. "Metabolic aspects of polycystic ovary syndrome." Thesis, University of Leeds, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.545722.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Baker, Elizabeth. "Illness Perceptions of Polycystic Ovary Syndrome." Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5176.

Full text
Abstract:
Polycystic ovary syndrome (PCOS) is a chronic illness that affects approximately five million premenopausal women in the United States and is associated with significant cosmetic, reproductive, metabolic, and psychological consequences. Despite its prevalence, few studies have explored the lived experiences and illness perceptions of women living with PCOS. Identifying illness perceptions of women living with (WLW) PCOS is important, because mounting research suggests that a person's perceptions of their chronic illness and its management determine that person's coping behaviors (e.g., adheren
APA, Harvard, Vancouver, ISO, and other styles
10

Lindholm, Åsa Maria. "Metabolic Aspects in the Polycystic Ovary Syndrome." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-120235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Best-Boss, Angie. Living with PCOS: Polycystic ovary syndrome. 2nd ed. Addicus Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Best-Boss, Angie. Living with P.C.O.S.: Polycystic ovary syndrome. Addicus Books, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Best-Boss, Angie. Living with PCOS: Polycystic ovary syndrome. 2nd ed. Addicus Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Evanthia, Diamanti-Kandarkis, ed. Insulin resistance and polycystic ovarian syndrome: Pathogenesis, evaluation, and treatment. Humana Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

H, Balen Adam, ed. Polycystic ovary syndrome: A guide to clinical management. Taylor & Francis, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wright, Hillary. The PCOS diet plan: A natural approach to health for women with polycystic ovary syndrome. Celestial Arts, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Y, Boutaleb, and Gzouli A, eds. The treatment of endometriosis--and other disorders and infections. Parthenon Pub. Group, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pal, Lubna, and David B. Seifer, eds. Polycystic Ovary Syndrome. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-92589-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pal, Lubna, ed. Polycystic Ovary Syndrome. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8394-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dunaif, Andrea, R. Jeffrey Chang, Stephen Franks, and Richard S. Legro, eds. Polycystic Ovary Syndrome. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-108-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Nader, Shahla. "Chronic Treatment of Polycystic Ovary Syndrome." In Insulin Resistance and Polycystic Ovarian Syndrome. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-310-3_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mintziori, Gesthimani, Dimitrios G. Goulis, and Basil C. Tarlatzis. "Polycystic Ovary Syndrome: Fertility Treatment Options." In ISGE Series. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63650-0_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baillargeon, Jean-Patrice, and Nadir R. Farid. "Medical Treatment." In Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09718-3_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pace, Joseph L. "The Polycystic Ovary Syndrome and Acne." In Pathogenesis and Treatment of Acne and Rosacea. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-540-69375-8_76.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wachs, Deborah S., and R. Jeffery Chang. "Treatment of Infertility in Polycystic Ovary Syndrome." In Insulin Resistance and Polycystic Ovarian Syndrome. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-310-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Himelein, Melissa J., and Samuel S. Thatcher. "Psychological Issues and Their Treatment." In Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09718-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stevenson, Emma. "Exercise in the Treatment of PCOS." In Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09718-3_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barry, John A. "Treatments for Improving Psychological Health in PCOS." In Psychological Aspects of Polycystic Ovary Syndrome. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30290-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ryan, Cynthia S., and John E. Nestler. "Insulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome." In Insulin Resistance and Polycystic Ovarian Syndrome. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-310-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Patel, Satin S., Victor E. Beshay, and Bruce R. Carr. "Metformin for the Treatment of Polycystic Ovary Syndrome (PCOS)." In Biennial Review of Infertility. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-392-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Ouyang, Tongxuan, Yu Chen, Yan Wang, Ying Xie, Haotian Li, and Min Zhao. "Exploring the mechanism of adjustment formula related to Siwu Decoction in the treatment of polycystic ovary syndrome based on network pharmacology." In 2024 IEEE International Conference on Big Data (BigData). IEEE, 2024. https://doi.org/10.1109/bigdata62323.2024.10825856.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

S, Vinothini, Vaishnavi S, and Mythili N. "Polycystic Ovary Syndrome (PCOS) Disease Prediction Using Machine Learning." In 2024 IEEE International Conference on Contemporary Computing and Communications (InC4). IEEE, 2024. http://dx.doi.org/10.1109/inc460750.2024.10649123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mahesswari, G. Umaa, P. Uma Maheswari, and B. Harini Priya. "IV3BoostPCOS: A Comprehensive Polycystic Ovary Syndrome (PCOS) Detection Framework." In 2024 IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE). IEEE, 2024. https://doi.org/10.1109/wiecon-ece64149.2024.10914947.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gorrab, Abir, Nourhène Ben Rabah, Isuri Kariyawasam, and Bénédicte Le Grand. "Advancing Polycystic Ovary Syndrome Detection with Artificial Intelligence Techniques." In 17th International Conference on Agents and Artificial Intelligence. SCITEPRESS - Science and Technology Publications, 2025. https://doi.org/10.5220/0013249800003890.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Madireddy, Vineela, Shaik Rehmat Sultana, Muddasani Ashvitha, and Yadasu Ajay. "Diagnosis of Polycystic Ovary Syndrome using Machine Learning Algorithms." In 2025 3rd International Conference on Self Sustainable Artificial Intelligence Systems (ICSSAS). IEEE, 2025. https://doi.org/10.1109/icssas66150.2025.11081296.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sri, Perarapu Lakshmi, M. R. Madhumita, Thanushri Madhuraj, Aadya Goel, Aadharsh Aadhithya A, and Soman K P. "ViT-PCOS: Vision Transformer for Automated Polycystic Ovary Syndrome Detection." In 2024 4th International Conference on Emerging Frontiers in Electrical and Electronic Technologies (ICEFEET). IEEE, 2024. https://doi.org/10.1109/icefeet64463.2024.10866446.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tasnim, Mayesha, Sejuty Das, Shafee Shadman Tonoy, and T. M. Shahriar Sazzad. "Follicle Detection in Polycystic Ovary Syndrome Using Ovarian Ultrasound Images." In 2025 International Conference on Electrical, Computer and Communication Engineering (ECCE). IEEE, 2025. https://doi.org/10.1109/ecce64574.2025.11013906.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Joy, Mrinmoy Saha, Nura Zabin, Sadia Islam, Marzia Binta Monir, and Nawshin Tabassum Tanny. "A Non-Invasive Approach for Early Polycystic Ovary Syndrome (PCOS) Prediction." In 2024 27th International Conference on Computer and Information Technology (ICCIT). IEEE, 2024. https://doi.org/10.1109/iccit64611.2024.11021753.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

PRATHIBANANDHI, J., and G. S. ANNIE GRACE VIMALA. "Detection of Polycystic Ovary Syndrome using Convolution Neural Network based Fuzzy Technique." In 2024 5th International Conference on Electronics and Sustainable Communication Systems (ICESC). IEEE, 2024. http://dx.doi.org/10.1109/icesc60852.2024.10689977.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

C N, Arpitha, Eshanya C. Y, Bhoomika G. V, Sinchana B. R, and Sridevi K. S. "Detection Of Polycystic Ovary Syndrome Using Machine Learning and Deep Learning Techniques." In 2024 Second International Conference on Advances in Information Technology (ICAIT). IEEE, 2024. http://dx.doi.org/10.1109/icait61638.2024.10690414.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Syndrome. Polycystic Ovary. Treatment"

1

Xu, Kou, Zhongyu Zhou, Wei Huang, Siying Lv, Yanji Zhang, and Chen Wan. Effectiveness and safety of moxibustion treatment for Polycystic Ovary Syndrome: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.11.0049.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hu, Yan, and YanYing Guo. The effectiveness and safety of exenatide in the treatment of polycystic ovary syndrome: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yu, Miao, and Dengchao Wang. Meta-analysis of the efficacy of metformin combined with traditional Chinese medicine in the treatment of obese polycystic ovary syndrome. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

LU, huili, hao LU, and dingwu ZHANG. The Efficacy and Safety of ketogenic diet in The Treatment of polycystic ovary syndrome ：A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.7.0024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yang, Liu, FX Liang, Y. Yuan, et al. Efficacy of progestin-primed ovarian stimulation (PPOS) in patients with polycystic ovary syndrome during IVF/ICSI treatments: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0059.

Full text
Abstract:
Review question / Objective: This systematic review aims to evaluate the efficacy of progestin-primed ovarian stimulation (PPOS) on reproductive outcomes in patients with polycystic ovary syndrome (PCOS) undergoing assisted reproductive techniques. Condition being studied: PCOS is a common endocrine disorder that can cause infertility in women of childbearing age. The PPOS protocol, which involves oral progestins with gonadotropin (Gn), has been shown to be effective and safe in treating patients with PCOS. However, the question of whether PPOS provides a significant benefit over conventional
APA, Harvard, Vancouver, ISO, and other styles
6

Ye, Wenguo, Gen Deng, Lin Yin, and Jing Ye. Efficacy and safety of moxibustion in the treatment of infertility with polycystic ovary syndrome: a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.1.0004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ren, Jian, Yan Xu, Chengfeng Liang, and Yu Sun. Clinical efficacy comparison of metformin and Myo-inositol in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Feng, Jing, Xiao-feng Zhang, Jie-ning Ren, Yu-hua Huang, and Xin Zheng. Efficacy of clomifene citrate combined Bushen Culuan Decoction for the treatment of infertility caused by polycystic ovary syndrome: a protocol of systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Glintborg, Dorte, Naja Due Kolster, Pernille Ravn, and Marianne Skovsager Andersen. Prospective risk of type 2 diabetes in normal weight women with polycystic ovary syndrome. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.6.0070.

Full text
Abstract:
Review question / Objective: To investigate the risk for type 2 diabetes (T2D) in normal weight women with PCOS. The following PECOs (Population, Exposure, Comparator and Outcome) were included: Population: Pre- and postmenopausal women. Exposure: PCOS Comparator: Healthy control or background population. Outcome: T2D. Condition being studied: Polycystic ovary syndrome (PCOS) is a common endocrine disorder of reproductive-aged women with a prevalence of 15–20%. Polycystic ovary syndrome (PCOS) is most often defined according to the Rotterdam criteria, which include irregular ovulation, biochem
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Shuai, and Xiaoxiao Lin. The effects of intermittent fasting for Polycystic ovary syndrome : a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.10.0020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Syndrome. Polycystic Ovary. Treatment' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography